The S&P/ASX Small Ordinaries Index closed down 5.20 points or 0.16% at 3,289.30 on Tuesday, trimming gains made over the past week. Despite the daily dip, the index remains up 1.80% over the last five trading sessions.
Several ASX-listed small-cap resource companies released updates and you can read about the following and more throughout the day:
European Lithium Ltd (ASX:EUR, OTCQB:EULIF) has begun a 2,000-metre diamond drilling program at the Tanbreez Rare Earth Project in Greenland as the company looks to expand the mineral resource estimate (MRE) for the Fjord Eudialyte Deposit, a key component of the Tanbreez project.
The drilling campaign will target extensions to the east of the existing Fjord Deposit. The current MRE for the deposit includes an Indicated resource of 8.76 million tonnes (Mt) and an Inferred resource of 13.8Mt, for a total of 22.56Mt.
Happy Creek Minerals Ltd. (TSX-V:HPY, OTC:HPYCF) said on Wednesday it had increased the size of its previously announced non-brokered private placement to C$3.75 million, following strong investor demand.
The financing includes charity flow-through units priced at C$0.07 and non-flow-through units at C$0.05, the Canadian junior miner said in a statement.
NanoViricides (NYSE-A:NNVC) is preparing for Phase II clinical testing in Africa, following the World Health Organization’s recent extension of the Public Health Emergency of International Concern (PHEIC) for the Mpox virus outbreak.
The extension, announced on July 10, comes amid rising cases of the Clade I strain of the Mpox virus (MPXV) in Africa, and sporadic travel-related cases outside the region, including the US, that pose a risk of sustained transmission.
Nevis Brands (CSE:NEVI, OTCQB:NEVIF) said on Wednesday it has signed an exclusive distribution agreement with ZT Distribution Inc. to expand the reach of its flagship hemp-derived THC beverage, Happy Apple, across key Midwest markets.
Under the agreement, ZT will distribute Happy Apple in Wisconsin and selected areas of Minnesota and Illinois, giving Nevis access to a network of more than 1,000 grocery stores and retailers.
Bit Digital Inc (NASDAQ:BTBT) said on Wednesday that its high-performance computing subsidiary WhiteFiber Inc has filed for an initial public offering in the US.
WhiteFiber plans to list its ordinary shares on the Nasdaq Capital Market under the ticker symbol "WYFI".
OKYO Pharma Ltd (NASDAQ:OKYO) on Wednesday reported promising top-line results from a Phase 2 trial of its investigational drug urcosimod for neuropathic corneal pain (NCP), with 75% of patients showing greater than 80% pain reduction after 12 weeks of treatment.
Patients treated with the 0.05% formulation of urcosimod saw a statistically significant reduction in pain scores compared to baseline, as measured by the Visual Analogue Scale (VAS), with an average improvement of 5.5 points versus 2.75 in the placebo group.
North Bay Resources Inc. (OTC:NBRI) has begun mobilizing for test mining at its Fran Gold Project in British Columbia after reporting a gold assay of 0.5 ounces per ton (14 grams per ton) from a massive sulphide outcrop between Trenches B and C.
The mineralized zone measures approximately 30 meters by 40 meters with a depth exceeding four meters, representing an estimated 15,000 tons of material, the company said in a statement.
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF) has announced that as part of a financial infrastructure upgrade it has introduced support for cryptocurrency payments in USD Coin (USDC) and Tether (USDT), and the rollout of ACH (Automated Clearing House) payments through its MapD event management platform.
The company, which specializes in AI-powered photorealistic 3D modeling and spatial experiences, said that these changes are part of its broader strategy to operate as a fully digital-first platform with improved cost efficiency and global payment flexibility.
Shares in Corero Network Security PLC (AIM:CNS, OTCQB:DDoSF) dropped 33% on Wednesday morning after the cyber-defence firm warned that full-year revenue and earnings would fall short of market expectations.
The AIM-listed company, which specialises in protecting against distributed denial of service (DDoS) attacks, said it was seeing strong momentum in its subscription-based model, with annualised recurring revenue rising 25% to $21.6 million.
Shares in Alien Metals (LSE:UFO) rose 17% in early trading on Wednesday after the company reported strikingly high-grade silver results from the first two holes of a new drilling programme at its Elizabeth Hill project in Western Australia.
The assays, released by joint venture partner West Coast Silver, included one interval of 21 metres grading 1,047 grams per tonne of silver from a depth of just 10 metres. That included a particularly rich one-metre section at over 15,000 grams per tonne.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) shares rose 5% in early trading on Wednesday after the company raised its 2025 production forecast, following record quarterly output from its Blanket Mine in Zimbabwe.
The gold miner reported second-quarter production of 21,070 ounces, slightly ahead of the same period last year and the highest total for a June quarter.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL, VFEX:CMCL) has raised its full-year gold production forecast after hitting a new quarterly output record at its Blanket Mine in Zimbabwe.
The company reported second-quarter production of 21,070 ounces of gold, narrowly surpassing the same period last year and setting a new high for the June quarter.
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) has begun the community resettlement process for its Tulu Kapi gold project in Ethiopia, marking a key milestone in preparations to move into full-scale development.
The AIM-listed mine developer said it would start paying compensation this month for the first phase of its action plan, with funds drawn from existing cash reserves following a recent capital raise.
Itaconix PLC (AIM:ITX, OTCQB:ITXXF) has expanded its partnership with Croda to supply plant-based ingredients for tackling unpleasant smells in household products, extending a longstanding collaboration and adding a new powder-based formulation aimed at the laundry market.
The AIM-quoted plant-based chemicals company said it would now supply ZINADOR 22D, a dry powder version of its odour neutraliser, alongside two existing liquid products already marketed globally by Croda.
Empire Metals Ltd (AIM:EEE, OTCQB:EPMLF) has made two key technical hires and entered a new consultancy partnership as it begins large-scale testing of its titanium project in Western Australia, a move it says will push the site closer to commercial production.
The London-listed mine developer has appointed the specialists to support the development of its Pitfield project, a site it describes as potentially hosting a “giant titanium system”.
Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF) has further strengthened its TRP-8803 clinical development team, with the appointments of Professor Marcel Mozafari as senior formulation scientist, and Professor David Castle as consultant medical officer.
The pair is set to significantly bolster Tryp's clinical development efforts, particularly in anticipation of the world-first trial of their lead drug candidate, TRP-8803, for the treatment of Binge Eating Disorder in collaboration with Swinburne University.
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has secured a landmark six-year exclusive distribution agreement worth up to US$317 million (A$487 million) with PHASE Scientific for its FebriDx® rapid point-of-care test in the United States, pending a Clinical Laboratory Improvement Amendments (CLIA) waiver from the United States Food and Drug Administration (FDA).
This marks a major inflection point in Lumos’ commercial trajectory and stands as one of the largest distribution deals executed by an ASX-listed point-of-care diagnostics company.
The first United States clinical trial site for Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF)’s Phase 2a study of PTX-100 has been initiated. The site at Virginia Commonwealth University’s (VCU) Massey Comprehensive Cancer Center is one of the top cancer research centres in the US, and the initiation marks a major milestone in the company’s global clinical development strategy.
The US launch adds to four patients already enrolled across three Australian sites, advancing the trial’s goal of recruiting up to 40 patients globally.